NO20064240L - Farmasoytiske forbindelser for oral administrasjon og fremgangsmate for fremstilling derav - Google Patents

Farmasoytiske forbindelser for oral administrasjon og fremgangsmate for fremstilling derav

Info

Publication number
NO20064240L
NO20064240L NO20064240A NO20064240A NO20064240L NO 20064240 L NO20064240 L NO 20064240L NO 20064240 A NO20064240 A NO 20064240A NO 20064240 A NO20064240 A NO 20064240A NO 20064240 L NO20064240 L NO 20064240L
Authority
NO
Norway
Prior art keywords
processes
preparation
oral administration
pharmaceutical compounds
composition
Prior art date
Application number
NO20064240A
Other languages
English (en)
Inventor
Claudia Mattern
Original Assignee
Mattern Udo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mattern Udo filed Critical Mattern Udo
Publication of NO20064240L publication Critical patent/NO20064240L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

Den foreliggende oppfinnelse vedrører en farmasøytisk blanding for oral tilførsel omfattende: i) et antelmintisk middel; ii) et første eksipiensmiddel med en porøs struktur med en indre overflate på fra omtrent 500 til 1500 m2/g; og et overflateareal ifølge BET på opptil omtrent 5000 m2/g; så vel som en metode for fremstilling av en slik blanding.
NO20064240A 2004-02-20 2006-09-19 Farmasoytiske forbindelser for oral administrasjon og fremgangsmate for fremstilling derav NO20064240L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04003906A EP1566173B1 (en) 2004-02-20 2004-02-20 Pharmaceutical composition for oral application and method for preparing thereof
PCT/EP2005/001297 WO2005079759A2 (en) 2004-02-20 2005-02-09 Pharmaceutical composition for oral application and method for preparing thereof

Publications (1)

Publication Number Publication Date
NO20064240L true NO20064240L (no) 2006-11-20

Family

ID=34707350

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064240A NO20064240L (no) 2004-02-20 2006-09-19 Farmasoytiske forbindelser for oral administrasjon og fremgangsmate for fremstilling derav

Country Status (16)

Country Link
US (1) US7767228B2 (no)
EP (2) EP1566173B1 (no)
JP (1) JP4800225B2 (no)
AT (1) ATE336230T1 (no)
AU (1) AU2005215108B2 (no)
BR (1) BRPI0507848A (no)
CA (1) CA2554640C (no)
DE (1) DE602004001969T2 (no)
DK (1) DK1566173T3 (no)
ES (1) ES2271714T3 (no)
NO (1) NO20064240L (no)
PT (1) PT1566173E (no)
RU (1) RU2342936C2 (no)
SI (1) SI1566173T1 (no)
WO (1) WO2005079759A2 (no)
ZA (1) ZA200606554B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2608505C (en) * 2005-05-18 2013-12-24 Da Volterra Colonic delivery of adsorbents
US8048413B2 (en) 2006-05-17 2011-11-01 Helene Huguet Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
UY31410A1 (es) * 2007-10-30 2009-05-29 Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado
JP2010106007A (ja) * 2008-08-14 2010-05-13 Sony Corp 薬剤徐放剤、吸着剤、機能性食品、マスク及び吸着シート
AU2009321822B2 (en) * 2008-12-05 2015-04-16 Bayer Intellectual Property Gmbh Extrudate having spicular active substances
HU231017B1 (hu) 2012-05-08 2019-11-28 LAVET Gyógyszeripari Kft. Praziquantel tartalmú ízfedett formulációk
RU2514056C2 (ru) * 2012-08-21 2014-04-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации Способ инкапсуляции фенбендазола
JP6472341B2 (ja) * 2015-06-26 2019-02-20 株式会社トーヨー技術研究所 固形状の魚類用経口投与薬剤、当該薬剤を含む養魚用飼料、および当該薬剤を魚に投与する方法
EP4208157A1 (en) 2020-09-04 2023-07-12 Elanco Us Inc. Palatable formulations
WO2023032048A1 (ja) * 2021-08-31 2023-03-09 株式会社トーヨー技術研究所 水棲動物用経口投与薬剤
WO2023032049A1 (ja) * 2021-08-31 2023-03-09 株式会社トーヨー技術研究所 水棲動物用経口投与薬剤

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1879601A (en) * 1926-03-13 1932-09-27 Merck & Co Inc Iodine composition
NL294490A (no) * 1962-06-25
US3709833A (en) * 1970-08-21 1973-01-09 Owens Illinois Inc Process for preparing high purity silicon oxide porous beads doped with small quantities of other oxides
US4581232A (en) * 1983-07-20 1986-04-08 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates
SU1465052A1 (ru) * 1985-06-10 1989-03-15 Институт Зоологии Ан Казсср Способ профилактики и лечени гельминтозов животных
US5013716A (en) * 1988-10-28 1991-05-07 Warner-Lambert Company Unpleasant taste masking compositions and methods for preparing same
JPH05238930A (ja) * 1992-02-28 1993-09-17 Eisai Co Ltd 持続性薬剤
IL139728A (en) * 1995-01-09 2003-06-24 Penwest Pharmaceuticals Compan Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US5827497A (en) * 1996-08-14 1998-10-27 Mayo Foundation For Medical Education And Research Charcoal-radionuclide agents for measurement of gastrointestinal transit
JP3950175B2 (ja) * 1997-05-30 2007-07-25 オスモティカ・コーポレイション 多層浸透デバイス
DE19726412A1 (de) * 1997-06-21 1998-12-24 Merck Patent Gmbh Implantatmaterial mit einer Träger-Wirkstoff-Kombination
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
JP3834732B2 (ja) * 1998-08-05 2006-10-18 株式会社ロッテ チューインガム
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6491949B2 (en) * 2000-01-14 2002-12-10 Osmotica Corp. Osmotic device within an osmotic device
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
EP1362583A1 (de) * 2002-05-15 2003-11-19 CUM Taste Masking AG Verfahren zur Geschmacksmaskierung von Substanzen durch Mikroverkapselung
US7001889B2 (en) * 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
EP2314171B1 (en) * 2002-08-13 2019-11-13 Intervet International BV Compositions and process for delivering an additive
CN100347889C (zh) * 2002-10-31 2007-11-07 松下电器产业株式会社 多孔电极及使用该电极的电化学元件

Also Published As

Publication number Publication date
ATE336230T1 (de) 2006-09-15
AU2005215108A1 (en) 2005-09-01
DE602004001969T2 (de) 2007-03-15
DK1566173T3 (da) 2006-12-27
CA2554640C (en) 2011-04-12
WO2005079759A3 (en) 2006-06-15
DE602004001969D1 (de) 2006-09-28
PT1566173E (pt) 2006-12-29
CA2554640A1 (en) 2005-09-01
BRPI0507848A (pt) 2007-07-10
WO2005079759A2 (en) 2005-09-01
EP1715850A2 (en) 2006-11-02
AU2005215108B2 (en) 2010-10-07
US7767228B2 (en) 2010-08-03
JP2007523108A (ja) 2007-08-16
ZA200606554B (en) 2008-05-28
RU2006133543A (ru) 2008-04-10
EP1566173A1 (en) 2005-08-24
SI1566173T1 (sl) 2006-12-31
EP1566173B1 (en) 2006-08-16
ES2271714T3 (es) 2007-04-16
US20050186272A1 (en) 2005-08-25
RU2342936C2 (ru) 2009-01-10
JP4800225B2 (ja) 2011-10-26

Similar Documents

Publication Publication Date Title
NO20064240L (no) Farmasoytiske forbindelser for oral administrasjon og fremgangsmate for fremstilling derav
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
NO20090328L (no) Nye forbindelser 385
NO20043367L (no) Oralt farmasoytisk preparat
EE200300373A (et) Meetod kamptotetsiini analoogide sünteesimiseks kasutatavate ühendite valmistamiseks ning kamptotetsiini analoogide terviksüntees
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
ATE556074T1 (de) Neue imidazoä1,5-aüpyridinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten
NO20081844L (no) Terapeutiske forbindelser
DE602005007339D1 (de) Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
NO20090327L (no) Nye forbindelser 384
AR054129A1 (es) Derivados de 2, 6-quinolinilo, una preparacion farmaceutica que los contiene y su empleo en la fabricacion de medicamentos para el tratamiento de enfermedades dependientes de integrinas alfa4beta1 y/o alfa4beta7
CY1112960T1 (el) Παραγωγα ουριας, μεθοδοι για την παρασκευη τους και χρησεις αυτων
WO2004100865A3 (en) New benzimidazole derivatives
EA200701687A1 (ru) Гидрохлорид аморфного лерканидипина
TW200800984A (en) New compounds
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
WO2006078724A3 (en) Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases
EA200801634A1 (ru) Твердая фармацевтическая композиция, содержащая ирбесартан
SE0401655D0 (sv) New compounds
EA200870223A1 (ru) Производные бензоизоиндола для лечения боли
WO2008039894A3 (en) Atorvastatin pharmaceutical compositions
MXPA05009686A (es) Composicion farmaceutica comprendiendo acido 5-metil-2-(2'-cloro-6'-fluoroanilino) fenilacetico.
ATE474558T1 (de) Pharmazeutische formulierungen mit irbesartan
CY1110814T1 (el) Νεα υποκατεστημενα αρυλοεξαδιενικα οξεα και εστερες αυτων τα οποια μπορουν να χρησιμοποιηθουν για την αγωγη και προληψη του διαβητη, δυσλιπιδαιμιας και αθηροσκληρωσης, φαρμακευτικες συνθεσεις που τα περιλαμβανουν και διεργασιες για την παρασκευη αυτων

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application